 | • レポートコード：MRC2-11QY11750 • 出版社/出版日：QYResearch / 2020年11月25日 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、98ページ • 納品方法：Eメール（納期：2~3日） • 産業分類：医療機器・消耗品 |
| Single User | ￥577,200 (USD3,900) | ▷ お問い合わせ |
| Multi User | ￥865,800 (USD5,850) | ▷ お問い合わせ |
| Enterprise License | ￥1,154,400 (USD7,800) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 当調査資料はEGFR変異検査のグローバル市場について調査・分析したレポートです。種類別（DNAシーケンシング、キット）市場規模、用途別（がん病院、臨床研究所）市場規模、地域別（北米、米国、カナダ、ヨーロッパ、ドイツ、フランス、イギリス、イタリア、ロシア、アジア、日本、中国、韓国、インド、オーストラリア、台湾、中南米、メキシコ、ブラジル、アルゼンチン、中東・アフリカ、トルコ、サウジアラビア、UAE等）市場規模データ、主な企業情報と企業別市場シェア等が収録されています。 ・調査範囲 ・エグゼクティブサマリー ・企業別EGFR変異検査の競争状況、市場シェア ・世界のEGFR変異検査市場：種類別市場規模 2015年-2020年（DNAシーケンシング、キット） ・世界のEGFR変異検査市場：種類別市場規模予測 2021年-2026年（DNAシーケンシング、キット） ・世界のEGFR変異検査市場：用途別市場規模 2015年-2020年（がん病院、臨床研究所） ・世界のEGFR変異検査市場：用途別市場規模予測 2021年-2026年（がん病院、臨床研究所） ・北米のEGFR変異検査市場分析：米国、カナダ ・ヨーロッパのEGFR変異検査市場分析：ドイツ、フランス、イギリス、イタリア、ロシア等 ・アジアのEGFR変異検査市場分析：日本、中国、韓国、インド、オーストラリア、台湾等 ・中南米のEGFR変異検査市場分析：メキシコ、ブラジル、アルゼンチン等 ・中東・アフリカのEGFR変異検査市場分析：トルコ、サウジアラビア、UAE等 ・企業情報（企業概要、製品概要、販売量、企業動向） - 掲載企業（変更可能性あり）：Abbott、Merck、Thermo Fisher Scientific、Illumina、BioMerieux、QIAGEN、Agilent Technologies、Hologic、Novartis、Roche、Genomic Health ・地域別市場規模予測（2021年-2026年）：北米市場、ヨーロッパ市場、アジア市場、中南米市場、中東・アフリカ市場 ・市場機会、課題、リスク、環境分析 ・バリューチェーン、販売チャネル分析 ・調査の結論 |
Epidermal growth factor receptor (EGFR) is a type of protein, which is located on the surface of human body cells. Any mutation in EGFR gene can lead to various types of cancer. EGFR functions as a biomarker for non-small cell lung cancer (NSCLC) and due to the mutation of EGFR gene a person may suffer from cancer or may have a tumor growth. Tumors with genetically altered EGFR gene are referred to as EGFR-mutated tumors. EGFR mutation is generally observed in NSCLCs, especially in adenocarcinoma tumors. According to the International Association for the Study of Lung Cancer, American Thoracic Society and European Respiratory Society, there are around 50% of surgically resected lung adenocarcinomas in EGFR mutations. These mutations are related to micro papillary predominant subtype and the bronchioloalveolar carcinoma. EGFR biomarker is used in diagnosis of patients with NSCLC. Targeted therapy involving tyrosine kinase inhibitors such as gefitinib and erotinib is used in the treatment of patients with NSCLC. EGFR biomarker detects the presence of specific alterations in EGFR gene, which may lead to the development of tumor.
Increasing global prevalence of lung cancer is expected to fuel growth of the global EGFR mutation test market over the forecast period. Increasing adoption of biomarker therapy is also expected to boost growth of the market worldwide over the forecast period.
Market Analysis and Insights: Global EGFR Mutation Test Market
The global EGFR Mutation Test market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX%% during 2021-2026.
Global EGFR Mutation Test Scope and Market Size
EGFR Mutation Test market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global EGFR Mutation Test market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2015-2026.
The key players covered in this study
Abbott
Merck
Thermo Fisher Scientific
Illumina
BioMerieux
QIAGEN
Agilent Technologies
Hologic
Novartis
Roche
Genomic Health
Market segment by Type, the product can be split into
DNA Sequencing
Kits
Market segment by Application, split into
Cancer Hospitals
Clinical Research Institutes
Market segment by Regions/Countries, this report covers
North America
Europe
China
Japan
Southeast Asia
India
1 Report Overview
1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered: Ranking by EGFR Mutation Test Revenue
1.4 Market by Type
1.4.1 Global EGFR Mutation Test Market Size Growth Rate by Type: 2020 VS 2026
1.4.2 DNA Sequencing
1.4.3 Kits
1.5 Market by Application
1.5.1 Global EGFR Mutation Test Market Share by Application: 2020 VS 2026
1.5.2 Cancer Hospitals
1.5.3 Clinical Research Institutes
1.6 Study Objectives
1.7 Years Considered
2 Global Growth Trends
2.1 Global EGFR Mutation Test Market Perspective (2015-2026)
2.2 Global EGFR Mutation Test Growth Trends by Regions
2.2.1 EGFR Mutation Test Market Size by Regions: 2015 VS 2020 VS 2026
2.2.2 EGFR Mutation Test Historic Market Share by Regions (2015-2020)
2.2.3 EGFR Mutation Test Forecasted Market Size by Regions (2021-2026)
2.3 Industry Trends and Growth Strategy
2.3.1 Market Top Trends
2.3.2 Market Drivers
2.3.3 Market Challenges
2.3.4 Porter’s Five Forces Analysis
2.3.5 EGFR Mutation Test Market Growth Strategy
2.3.6 Primary Interviews with Key EGFR Mutation Test Players (Opinion Leaders)
3 Competition Landscape by Key Players
3.1 Global Top EGFR Mutation Test Players by Market Size
3.1.1 Global Top EGFR Mutation Test Players by Revenue (2015-2020)
3.1.2 Global EGFR Mutation Test Revenue Market Share by Players (2015-2020)
3.1.3 Global EGFR Mutation Test Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.2 Global EGFR Mutation Test Market Concentration Ratio
3.2.1 Global EGFR Mutation Test Market Concentration Ratio (CR5 and HHI)
3.2.2 Global Top 10 and Top 5 Companies by EGFR Mutation Test Revenue in 2019
3.3 EGFR Mutation Test Key Players Head office and Area Served
3.4 Key Players EGFR Mutation Test Product Solution and Service
3.5 Date of Enter into EGFR Mutation Test Market
3.6 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type (2015-2026)
4.1 Global EGFR Mutation Test Historic Market Size by Type (2015-2020)
4.2 Global EGFR Mutation Test Forecasted Market Size by Type (2021-2026)
5 Market Size by Application (2015-2026)
5.1 Global EGFR Mutation Test Market Size by Application (2015-2020)
5.2 Global EGFR Mutation Test Forecasted Market Size by Application (2021-2026)
6 North America
6.1 North America EGFR Mutation Test Market Size (2015-2020)
6.2 EGFR Mutation Test Key Players in North America (2019-2020)
6.3 North America EGFR Mutation Test Market Size by Type (2015-2020)
6.4 North America EGFR Mutation Test Market Size by Application (2015-2020)
7 Europe
7.1 Europe EGFR Mutation Test Market Size (2015-2020)
7.2 EGFR Mutation Test Key Players in Europe (2019-2020)
7.3 Europe EGFR Mutation Test Market Size by Type (2015-2020)
7.4 Europe EGFR Mutation Test Market Size by Application (2015-2020)
8 China
8.1 China EGFR Mutation Test Market Size (2015-2020)
8.2 EGFR Mutation Test Key Players in China (2019-2020)
8.3 China EGFR Mutation Test Market Size by Type (2015-2020)
8.4 China EGFR Mutation Test Market Size by Application (2015-2020)
9 Japan
9.1 Japan EGFR Mutation Test Market Size (2015-2020)
9.2 EGFR Mutation Test Key Players in Japan (2019-2020)
9.3 Japan EGFR Mutation Test Market Size by Type (2015-2020)
9.4 Japan EGFR Mutation Test Market Size by Application (2015-2020)
10 Southeast Asia
10.1 Southeast Asia EGFR Mutation Test Market Size (2015-2020)
10.2 EGFR Mutation Test Key Players in Southeast Asia (2019-2020)
10.3 Southeast Asia EGFR Mutation Test Market Size by Type (2015-2020)
10.4 Southeast Asia EGFR Mutation Test Market Size by Application (2015-2020)
11 India
11.1 India EGFR Mutation Test Market Size (2015-2020)
11.2 EGFR Mutation Test Key Players in India (2019-2020)
11.3 India EGFR Mutation Test Market Size by Type (2015-2020)
11.4 India EGFR Mutation Test Market Size by Application (2015-2020)
12 Central & South America
12.1 Central & South America EGFR Mutation Test Market Size (2015-2020)
12.2 EGFR Mutation Test Key Players in Central & South America (2019-2020)
12.3 Central & South America EGFR Mutation Test Market Size by Type (2015-2020)
12.4 Central & South America EGFR Mutation Test Market Size by Application (2015-2020)
13 Key Players Profiles
13.1 Abbott
13.1.1 Abbott Company Details
13.1.2 Abbott Business Overview
13.1.3 Abbott EGFR Mutation Test Introduction
13.1.4 Abbott Revenue in EGFR Mutation Test Business (2015-2020))
13.1.5 Abbott Recent Development
13.2 Merck
13.2.1 Merck Company Details
13.2.2 Merck Business Overview
13.2.3 Merck EGFR Mutation Test Introduction
13.2.4 Merck Revenue in EGFR Mutation Test Business (2015-2020)
13.2.5 Merck Recent Development
13.3 Thermo Fisher Scientific
13.3.1 Thermo Fisher Scientific Company Details
13.3.2 Thermo Fisher Scientific Business Overview
13.3.3 Thermo Fisher Scientific EGFR Mutation Test Introduction
13.3.4 Thermo Fisher Scientific Revenue in EGFR Mutation Test Business (2015-2020)
13.3.5 Thermo Fisher Scientific Recent Development
13.4 Illumina
13.4.1 Illumina Company Details
13.4.2 Illumina Business Overview
13.4.3 Illumina EGFR Mutation Test Introduction
13.4.4 Illumina Revenue in EGFR Mutation Test Business (2015-2020)
13.4.5 Illumina Recent Development
13.5 BioMerieux
13.5.1 BioMerieux Company Details
13.5.2 BioMerieux Business Overview
13.5.3 BioMerieux EGFR Mutation Test Introduction
13.5.4 BioMerieux Revenue in EGFR Mutation Test Business (2015-2020)
13.5.5 BioMerieux Recent Development
13.6 QIAGEN
13.6.1 QIAGEN Company Details
13.6.2 QIAGEN Business Overview
13.6.3 QIAGEN EGFR Mutation Test Introduction
13.6.4 QIAGEN Revenue in EGFR Mutation Test Business (2015-2020)
13.6.5 QIAGEN Recent Development
13.7 Agilent Technologies
13.7.1 Agilent Technologies Company Details
13.7.2 Agilent Technologies Business Overview
13.7.3 Agilent Technologies EGFR Mutation Test Introduction
13.7.4 Agilent Technologies Revenue in EGFR Mutation Test Business (2015-2020)
13.7.5 Agilent Technologies Recent Development
13.8 Hologic
13.8.1 Hologic Company Details
13.8.2 Hologic Business Overview
13.8.3 Hologic EGFR Mutation Test Introduction
13.8.4 Hologic Revenue in EGFR Mutation Test Business (2015-2020)
13.8.5 Hologic Recent Development
13.9 Novartis
13.9.1 Novartis Company Details
13.9.2 Novartis Business Overview
13.9.3 Novartis EGFR Mutation Test Introduction
13.9.4 Novartis Revenue in EGFR Mutation Test Business (2015-2020)
13.9.5 Novartis Recent Development
13.10 Roche
13.10.1 Roche Company Details
13.10.2 Roche Business Overview
13.10.3 Roche EGFR Mutation Test Introduction
13.10.4 Roche Revenue in EGFR Mutation Test Business (2015-2020)
13.10.5 Roche Recent Development
13.11 Genomic Health
10.11.1 Genomic Health Company Details
10.11.2 Genomic Health Business Overview
10.11.3 Genomic Health EGFR Mutation Test Introduction
10.11.4 Genomic Health Revenue in EGFR Mutation Test Business (2015-2020)
10.11.5 Genomic Health Recent Development
14 Analyst’s Viewpoints/Conclusions
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Disclaimer
15.3 Author Details
Table 1. EGFR Mutation Test Key Market Segments
Table 2. Key Players Covered: Ranking by EGFR Mutation Test Revenue
Table 3. Ranking of Global Top EGFR Mutation Test Manufacturers by Revenue (US$ Million) in 2019
Table 4. Global EGFR Mutation Test Market Size Growth Rate by Type (US$ Million): 2020 VS 2026
Table 5. Key Players of DNA Sequencing
Table 6. Key Players of Kits
Table 7. Global EGFR Mutation Test Market Size Growth by Application (US$ Million): 2020 VS 2026
Table 8. Global EGFR Mutation Test Market Size by Regions (US$ Million): 2020 VS 2026
Table 9. Global EGFR Mutation Test Market Size by Regions (2015-2020) (US$ Million)
Table 10. Global EGFR Mutation Test Market Share by Regions (2015-2020)
Table 11. Global EGFR Mutation Test Forecasted Market Size by Regions (2021-2026) (US$ Million)
Table 12. Global EGFR Mutation Test Market Share by Regions (2021-2026)
Table 13. Market Top Trends
Table 14. Key Drivers: Impact Analysis
Table 15. Key Challenges
Table 16. EGFR Mutation Test Market Growth Strategy
Table 17. Main Points Interviewed from Key EGFR Mutation Test Players
Table 18. Global EGFR Mutation Test Revenue by Players (2015-2020) (Million US$)
Table 19. Global EGFR Mutation Test Market Share by Players (2015-2020)
Table 20. Global Top EGFR Mutation Test Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in EGFR Mutation Test as of 2019)
Table 21. Global EGFR Mutation Test by Players Market Concentration Ratio (CR5 and HHI)
Table 22. Key Players Headquarters and Area Served
Table 23. Key Players EGFR Mutation Test Product Solution and Service
Table 24. Date of Enter into EGFR Mutation Test Market
Table 25. Mergers & Acquisitions, Expansion Plans
Table 26. Global EGFR Mutation Test Market Size by Type (2015-2020) (Million US$)
Table 27. Global EGFR Mutation Test Market Size Share by Type (2015-2020)
Table 28. Global EGFR Mutation Test Revenue Market Share by Type (2021-2026)
Table 29. Global EGFR Mutation Test Market Size Share by Application (2015-2020)
Table 30. Global EGFR Mutation Test Market Size by Application (2015-2020) (Million US$)
Table 31. Global EGFR Mutation Test Market Size Share by Application (2021-2026)
Table 32. North America Key Players EGFR Mutation Test Revenue (2019-2020) (Million US$)
Table 33. North America Key Players EGFR Mutation Test Market Share (2019-2020)
Table 34. North America EGFR Mutation Test Market Size by Type (2015-2020) (Million US$)
Table 35. North America EGFR Mutation Test Market Share by Type (2015-2020)
Table 36. North America EGFR Mutation Test Market Size by Application (2015-2020) (Million US$)
Table 37. North America EGFR Mutation Test Market Share by Application (2015-2020)
Table 38. Europe Key Players EGFR Mutation Test Revenue (2019-2020) (Million US$)
Table 39. Europe Key Players EGFR Mutation Test Market Share (2019-2020)
Table 40. Europe EGFR Mutation Test Market Size by Type (2015-2020) (Million US$)
Table 41. Europe EGFR Mutation Test Market Share by Type (2015-2020)
Table 42. Europe EGFR Mutation Test Market Size by Application (2015-2020) (Million US$)
Table 43. Europe EGFR Mutation Test Market Share by Application (2015-2020)
Table 44. China Key Players EGFR Mutation Test Revenue (2019-2020) (Million US$)
Table 45. China Key Players EGFR Mutation Test Market Share (2019-2020)
Table 46. China EGFR Mutation Test Market Size by Type (2015-2020) (Million US$)
Table 47. China EGFR Mutation Test Market Share by Type (2015-2020)
Table 48. China EGFR Mutation Test Market Size by Application (2015-2020) (Million US$)
Table 49. China EGFR Mutation Test Market Share by Application (2015-2020)
Table 50. Japan Key Players EGFR Mutation Test Revenue (2019-2020) (Million US$)
Table 51. Japan Key Players EGFR Mutation Test Market Share (2019-2020)
Table 52. Japan EGFR Mutation Test Market Size by Type (2015-2020) (Million US$)
Table 53. Japan EGFR Mutation Test Market Share by Type (2015-2020)
Table 54. Japan EGFR Mutation Test Market Size by Application (2015-2020) (Million US$)
Table 55. Japan EGFR Mutation Test Market Share by Application (2015-2020)
Table 56. Southeast Asia Key Players EGFR Mutation Test Revenue (2019-2020) (Million US$)
Table 57. Southeast Asia Key Players EGFR Mutation Test Market Share (2019-2020)
Table 58. Southeast Asia EGFR Mutation Test Market Size by Type (2015-2020) (Million US$)
Table 59. Southeast Asia EGFR Mutation Test Market Share by Type (2015-2020)
Table 60. Southeast Asia EGFR Mutation Test Market Size by Application (2015-2020) (Million US$)
Table 61. Southeast Asia EGFR Mutation Test Market Share by Application (2015-2020)
Table 62. India Key Players EGFR Mutation Test Revenue (2019-2020) (Million US$)
Table 63. India Key Players EGFR Mutation Test Market Share (2019-2020)
Table 64. India EGFR Mutation Test Market Size by Type (2015-2020) (Million US$)
Table 65. India EGFR Mutation Test Market Share by Type (2015-2020)
Table 66. India EGFR Mutation Test Market Size by Application (2015-2020) (Million US$)
Table 67. India EGFR Mutation Test Market Share by Application (2015-2020)
Table 68. Central & South America Key Players EGFR Mutation Test Revenue (2019-2020) (Million US$)
Table 69. Central & South America Key Players EGFR Mutation Test Market Share (2019-2020)
Table 70. Central & South America EGFR Mutation Test Market Size by Type (2015-2020) (Million US$)
Table 71. Central & South America EGFR Mutation Test Market Share by Type (2015-2020)
Table 72. Central & South America EGFR Mutation Test Market Size by Application (2015-2020) (Million US$)
Table 73. Central & South America EGFR Mutation Test Market Share by Application (2015-2020)
Table 74. Abbott Company Details
Table 75. Abbott Business Overview
Table 76. Abbott Product
Table 77. Abbott Revenue in EGFR Mutation Test Business (2015-2020) (Million US$)
Table 78. Abbott Recent Development
Table 79. Merck Company Details
Table 80. Merck Business Overview
Table 81. Merck Product
Table 82. Merck Revenue in EGFR Mutation Test Business (2015-2020) (Million US$)
Table 83. Merck Recent Development
Table 84. Thermo Fisher Scientific Company Details
Table 85. Thermo Fisher Scientific Business Overview
Table 86. Thermo Fisher Scientific Product
Table 87. Thermo Fisher Scientific Revenue in EGFR Mutation Test Business (2015-2020) (Million US$)
Table 88. Thermo Fisher Scientific Recent Development
Table 89. Illumina Company Details
Table 90. Illumina Business Overview
Table 91. Illumina Product
Table 92. Illumina Revenue in EGFR Mutation Test Business (2015-2020) (Million US$)
Table 93. Illumina Recent Development
Table 94. BioMerieux Company Details
Table 95. BioMerieux Business Overview
Table 96. BioMerieux Product
Table 97. BioMerieux Revenue in EGFR Mutation Test Business (2015-2020) (Million US$)
Table 98. BioMerieux Recent Development
Table 99. QIAGEN Company Details
Table 100. QIAGEN Business Overview
Table 101. QIAGEN Product
Table 102. QIAGEN Revenue in EGFR Mutation Test Business (2015-2020) (Million US$)
Table 103. QIAGEN Recent Development
Table 104. Agilent Technologies Company Details
Table 105. Agilent Technologies Business Overview
Table 106. Agilent Technologies Product
Table 107. Agilent Technologies Revenue in EGFR Mutation Test Business (2015-2020) (Million US$)
Table 108. Agilent Technologies Recent Development
Table 109. Hologic Business Overview
Table 110. Hologic Product
Table 111. Hologic Company Details
Table 112. Hologic Revenue in EGFR Mutation Test Business (2015-2020) (Million US$)
Table 113. Hologic Recent Development
Table 114. Novartis Company Details
Table 115. Novartis Business Overview
Table 116. Novartis Product
Table 117. Novartis Revenue in EGFR Mutation Test Business (2015-2020) (Million US$)
Table 118. Novartis Recent Development
Table 119. Roche Company Details
Table 120. Roche Business Overview
Table 121. Roche Product
Table 122. Roche Revenue in EGFR Mutation Test Business (2015-2020) (Million US$)
Table 123. Roche Recent Development
Table 124. Genomic Health Company Details
Table 125. Genomic Health Business Overview
Table 126. Genomic Health Product
Table 127. Genomic Health Revenue in EGFR Mutation Test Business (2015-2020) (Million US$)
Table 128. Genomic Health Recent Development
Table 129. Research Programs/Design for This Report
Table 130. Key Data Information from Secondary Sources
Table 131. Key Data Information from Primary Sources
List of Figures
Figure 1. Global EGFR Mutation Test Market Share by Type: 2020 VS 2026
Figure 2. DNA Sequencing Features
Figure 3. Kits Features
Figure 4. Global EGFR Mutation Test Market Share by Application: 2020 VS 2026
Figure 5. Cancer Hospitals Case Studies
Figure 6. Clinical Research Institutes Case Studies
Figure 7. EGFR Mutation Test Report Years Considered
Figure 8. Global EGFR Mutation Test Market Size YoY Growth 2015-2026 (US$ Million)
Figure 9. Global EGFR Mutation Test Market Share by Regions: 2020 VS 2026
Figure 10. Global EGFR Mutation Test Market Share by Regions (2021-2026)
Figure 11. Porter's Five Forces Analysis
Figure 12. Global EGFR Mutation Test Market Share by Players in 2019
Figure 13. Global Top EGFR Mutation Test Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in EGFR Mutation Test as of 2019
Figure 14. The Top 10 and 5 Players Market Share by EGFR Mutation Test Revenue in 2019
Figure 15. North America EGFR Mutation Test Market Size YoY Growth (2015-2020) (Million US$)
Figure 16. Europe EGFR Mutation Test Market Size YoY Growth (2015-2020) (Million US$)
Figure 17. China EGFR Mutation Test Market Size YoY Growth (2015-2020) (Million US$)
Figure 18. Japan EGFR Mutation Test Market Size YoY Growth (2015-2020) (Million US$)
Figure 19. Southeast Asia EGFR Mutation Test Market Size YoY Growth (2015-2020) (Million US$)
Figure 20. India EGFR Mutation Test Market Size YoY Growth (2015-2020) (Million US$)
Figure 21. Central & South America EGFR Mutation Test Market Size YoY Growth (2015-2020) (Million US$)
Figure 22. Bottom-up and Top-down Approaches for This Report
Figure 23. Data Triangulation
Figure 24. Key Executives Interviewed
突然変異生成システムの世界市場（～2026年） The mutation generation system is used for the functional analysis of the proteins. The mutation generation system enables the saturated libraries of transformed proteins in a response within a very less duration of time. The mutation generation system is a complete package of reagents for transposo…- 腫瘍バイオマーカー検査の世界市場（～2026年） Market Analysis and Insights: Global Tumor Biomarker Test Market The global Tumor Biomarker Test market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX%% during 2021-2026. Global Tumor Biomarker Test Scope and Market Size Tumor Biomarker Test market is…
- 子宮頸がん診断検査の世界市場（～2026年） Market Analysis and Insights: Global Cervical Cancer Diagnostic Test Market The global Cervical Cancer Diagnostic Test market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX% during 2021-2026. With industry-standard accuracy in analysis and high data i…
- 妊娠検査キットの世界市場（～2026年） A pregnancy test attempts to determine whether or not a woman is pregnant. Indicative markers are found in blood and urine, and pregnancy tests require sampling one of these substances. Pregnancy test kits are medical devices which are used to identify the possibility of pregnancy in females. The de…
- 貧血・ビタミン検査の世界市場（～2026年） Anemia is a clinical condition where the human body does not have enough Red Blood Cells (RBC) or Haemoglobin or both which are paramount important to functioning of the human being. Haemoglobin is a part of RBC that carries oxygen to the various body tissue. If a person has less number of RBC or lo…